CORRESP 1 filename1.htm nby20190910_corresp.htm

 

 

September 11, 2019

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

Re:

NovaBay Pharmaceuticals, Inc. (the “Company”)

Form S-3, File No. 333-233623

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective as of 5:00 p.m. (Eastern time) on Thursday, September 12, 2019, or as soon as practicable thereafter.

 

 

   

Very truly yours,
       
   

NovaBay Pharmaceuticals, Inc.
       
       
   

By:

 /s/ Justin Hall 
     

Justin Hall
     

President & Chief Executive Officer and General Counsel
       
       

cc:

Abby E. Brown, Squire Patton Boggs (US) LLP